Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasir Z Sulemanjee

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|July 18, 2006
Conivaptan: a selective vasopressin antagonistNasir Z Sulemanjee, Ernst R Schwarz
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 26, 2014
Practical value of identifying antibodies to cryptic HLA epitopes in cardiac transplantationMartin Oaks, Karen Michel, Nasir Z Sulemanjee, et al.
Echocardiography (Mount Kisco, N.Y.)|February 11, 2014
Cardiac sarcoid: a chameleon masquerading as hypertrophic cardiomyopathy and dilated cardiomyopathy in the same patientAnushree Agarwal, Nasir Z Sulemanjee, Omar Cheema, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 29, 2005
Monocyte chemoattractant protein 1-induced monocyte infiltration produces angiogenesis but not arteriogenesis in chronically infarcted myocardiumErnst R Schwarz, Dennis A Meven, Nasir Z Sulemanjee, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 22, 2008
The first year post-heart transplantation: use of immunosuppressive drugs and early complicationsNasir Z Sulemanjee, Ramanna Merla, Scott D Lick, et al.
Journal of Cardiac Surgery|May 7, 2019
The association between novel clinical factors and gastrointestinal bleeding among patients supported with continuous-flow left ventricular assist device therapyVinay Thohan, Yang Shi, Matthew Rappelt, et al.
International Journal of Cardiology|September 7, 2017
Malignant cardiac phenotypic expression of Danon disease (LAMP2 cardiomyopathy)Fatima Samad, Renuka Jain, M Fuad Jan, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 14, 2019
Benefits of Neurohormonal Therapy in Patients With Continuous-Flow Left Ventricular Assist DevicesRayan Yousefzai, Michela Brambatti, Hao A Tran, et al.
BMC Medical Informatics and Decision Making|March 21, 2021
A principal components analysis of factors associated with successful implementation of an LVAD decision support toolKristin M Kostick, Meredith Trejo, Arvind Bhimaraj, et al.
Journal of Cardiac Failure|September 29, 2025
Hemodynamic Profiles During Pulmonary Artery Pressure Sensor Implantation: Risk Stratification in Chronic Heart Failure With Reduced Ejection FractionDaniel Jabr, Rachel Pedersen, Amogha Dahal, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Drugs of Today (Barcelona, Spain : 1998)|July 18, 2006
Conivaptan: a selective vasopressin antagonistNasir Z Sulemanjee, Ernst R Schwarz
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 26, 2014
Practical value of identifying antibodies to cryptic HLA epitopes in cardiac transplantationMartin Oaks, Karen Michel, Nasir Z Sulemanjee, et al.
Echocardiography (Mount Kisco, N.Y.)|February 11, 2014
Cardiac sarcoid: a chameleon masquerading as hypertrophic cardiomyopathy and dilated cardiomyopathy in the same patientAnushree Agarwal, Nasir Z Sulemanjee, Omar Cheema, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 29, 2005
Monocyte chemoattractant protein 1-induced monocyte infiltration produces angiogenesis but not arteriogenesis in chronically infarcted myocardiumErnst R Schwarz, Dennis A Meven, Nasir Z Sulemanjee, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 22, 2008
The first year post-heart transplantation: use of immunosuppressive drugs and early complicationsNasir Z Sulemanjee, Ramanna Merla, Scott D Lick, et al.
Journal of Cardiac Surgery|May 7, 2019
The association between novel clinical factors and gastrointestinal bleeding among patients supported with continuous-flow left ventricular assist device therapyVinay Thohan, Yang Shi, Matthew Rappelt, et al.
International Journal of Cardiology|September 7, 2017
Malignant cardiac phenotypic expression of Danon disease (LAMP2 cardiomyopathy)Fatima Samad, Renuka Jain, M Fuad Jan, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 14, 2019
Benefits of Neurohormonal Therapy in Patients With Continuous-Flow Left Ventricular Assist DevicesRayan Yousefzai, Michela Brambatti, Hao A Tran, et al.
BMC Medical Informatics and Decision Making|March 21, 2021
A principal components analysis of factors associated with successful implementation of an LVAD decision support toolKristin M Kostick, Meredith Trejo, Arvind Bhimaraj, et al.
Journal of Cardiac Failure|September 29, 2025
Hemodynamic Profiles During Pulmonary Artery Pressure Sensor Implantation: Risk Stratification in Chronic Heart Failure With Reduced Ejection FractionDaniel Jabr, Rachel Pedersen, Amogha Dahal, et al.
Pageof 2